News

Correvio Pharma Corp., a revenue-generating, specialty pharmaceutical company focused on providing innovative, high-quality brands that meet the needs of acute care physicians and patients, announced that Brinavess®  (vernakalant...

The latest results from the Global Anticoagulant Registry in the Field - Atrial Fibrillation (GARFIELD-AF) will be presented at the forthcoming ESC Congress 2018, organised by the European Society of Cardiology, to be held in Munich, Germany,...

Verseon’s drug discovery program, based on an industry-leading in silico platform, progresses four programs with multiple novel compounds in anticoagulation, HAE, DME, and oncology. Anticoagulants Verseon has submitted the Phase I protocol...

Thermedical® announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for the Early Feasibility Study (EFS) of the groundbreaking Durablate™ ablation catheter. The...

MEDICALgorithmics, S.A. and U.S. subsidiary Medi-Lynx Cardiac Monitoring L.L.C., announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the PocketECG Cardiac Rehabilitation System (CRS), a new mobile...

Medtronic plc announced first enrollments in a new clinical trial evaluating the ECG (electrocardiography) Belt Research System (ECG Belt) as a diagnostic tool for optimizing cardiac resynchronization therapy (CRT) for patients with...

OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, announced results from its first-in-human...

Geneva Health Solutions (GHS), the leading cloud-based technology platform and service for managing data from implantable cardiac devices, announced it has hit a critical milestone for the number of practices using the GHS remote monitoring...

CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for atrial fibrillation (AF), announced the commercial launch of its HeartLight Endoscopic Ablation System in Japan. The commercial...

BioSig Technologies, Inc., a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, announced that the...